
Kimberly-Clark (KMB) Stock Forecast & Price Target
Kimberly-Clark (KMB) Analyst Ratings
Bulls say
Kimberly-Clark is well-positioned in the tissue and hygiene market, with strong brand presence and a diverse portfolio of products. Although cost pressures may have a short-term impact on earnings in 2026, the company has hedged a significant portion of its input costs and has a strong strategy in place to mitigate these pressures through productivity and pricing efforts. Furthermore, Kimberly-Clark's acquisition of Kenvue in the second half of 2026 will provide potential for significant upside in 2028 and beyond through cost synergies and savings. However, there is potential risk to 2027 earnings if the current spike in oil-derived input costs persists. Additionally, while the company has seen a lift in sales in the first quarter of 2026, challenging market conditions may continue to impact growth. Overall, with a solid foundation and potential for future growth, Kimberly-Clark remains a positive investment opportunity.
Bears say
Kimberly-Clark is facing headwinds in its North American personal care and consumer tissue segments, with softer category momentum and a warehouse fire negatively impacting sales. Additionally, the company is exposed to potential cost increases due to its reliance on oil-derived inputs, which have seen a significant increase in price. This, combined with tough comps in the second quarter and only modest growth expectations for the future, makes us cautious on the company's stock.
This aggregate rating is based on analysts' research of Kimberly-Clark and is not a guaranteed prediction by Public.com or investment advice.
Kimberly-Clark (KMB) Analyst Forecast & Price Prediction
Start investing in Kimberly-Clark (KMB)
Order type
Buy in
Order amount
Est. shares
0 shares